Global Nerve Repair And Regeneration Market

Global Nerve Repair and Regeneration Market, By Product (Neurostimulation And Neuromodulation Devices), By Application (Neurostimulation & Neuromodulation Applications, Nerve Repair & Regeneration Biomaterials), By Region (North America, Europe, Asia-Pacific (APAC), Latin America (LATAM), Middle-East & Africa (MEA) Trend Analysis, Competitive Market Share & Forecast, 2017-2027

  • Published Date: August 2021
  • Report ID: BWC2159
  • Available Format: PDF
  • Page: 190
  1. Research Framework
    1. Research Objective
    2. Product Overview
    3. Market Segmentation
  2. Research Methodology
    1. Qualitative Research
      1. Primary and Secondary Sources
    2. Quantitative Research
      1. Primary and Secondary Sources
    3. Breakdown of Primary Research Respondents
      1. Secondary Research
      2. Primary Research
    4. Breakdown of Primary Research Respondents, By Industry Participants
    5. Key Questionnaire asked during Primary Interviews
    6. Key Primary Responses
    7. Market Size Estimation
    8. Assumption for the Study
    9. Market Breakdown & Data Triangulation
  3. Executive Summary
  4. Global Nerve Repair and Regeneration Market – Industry Insights
    1. DROC Analysis
      1. Growth Drivers
      2. Restraints
      3. Opportunity
      4. Challenges
    2. Recent Developments / Technical Landscape
    3. Regulatory Framework
    4. Porter’s Five Forces Analysis
    5. Value Chain Analysis
    6. Strategic Outlook
  5. Global Nerve Repair and Regeneration Market Overview
    1. Market Estimates & Forecast by Value, 2017-2027
      1. By Value (USD Billion)
    2. Market Share & Forecast
      1. By Product
        1. Neurostimulation And Neuromodulation Devices
          1. Internal Neurostimulation And Neuromodulation Devices
          2. External Neurostimulation And Neuromodulation Devices
          3. Biomaterials
      2. By Application
        1. Neurostimulation & Neuromodulation Applications
          1. Internal Neurostimulation & Neuromodulation
          2. External Neurostimulation & Neuromodulation
        2. Nerve Repair & Regeneration Biomaterials
          1. Direct Nerve Repair/Neurorrhaphy
          2. Nerve Grafting
          3. Stem Cell Therapy
      3. By Region
        1. North America
        2. Europe
        3. Asia-Pacific (APAC)
        4. Latin America (LATAM)
        5. Middle-East & Africa (MEA)
  6. North America Nerve Repair andRegeneration Market Overview
    1. Market Size and Forecast
      1. By Value (USD Billion), 2017-2027
    2. Market Share and Forecast
      1. By Product
      2. By Application
      3. By Country
        1. U.S.
        2. Canada
  7. Europe Nerve Repair and Regeneration Market Overview
    1. Market Size and Forecast
      1. By Value (USD Billion), 2017-2027
    2. Market Share and Forecast
      1. By Product
      2. By Application
      3. By Country
        1. Germany
        2. U.K.
        3. France
        4. Italy
        5. Spain
        6. Russia
        7. Netherlands
        8. Rest of Europe
  8. APAC Nerve Repair and Regeneration Market Overview
    1. Market Size and Forecast
      1. By Value (USD Billion), 2017-2027
    2. Market Share and Forecast
      1. By Product
      2. By Application
      3. By Country
        1. China
        2. India
        3. Japan
        4. South Korea
        5. Rest of APAC
  9. LATAM Nerve Repair and Regeneration Market Overview
    1. Market Size and Forecast
      1. By Value (USD Billion), 2017-2027
    2. Market Share and Forecast
      1. By Product
      2. By Application
      3. By Country
        1. Mexico
        2. Brazil
        3. Rest of LATAM
  10. MEA Nerve Repair and Regeneration Market Overview
    1. Market Size and Forecast
      1. By Value (USD Billion), 2017-2027
    2. Market Share and Forecast
      1. By Product
      2. By Application
      3. By Country
        1. Saudi Arabia
        2. UAE
        3. South Africa
        4. Turkey
        5. Rest of Europe
  11. Competitive Landscape
      1. List of Key Players and Their Offerings
      2. Market Share / Ranking Analysis (2020)
      3. Competitive Benchmarking, By Operating Parameters
  12. COVID-19 Impact
  13. Company Profiles (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook) *
    1. Stryker
    2. Neuropace Inc.
    3. Livanova
    4. Boston Scientific Corporation
    5. Axogen Corporation
    6. Neuronetics
    7. Medtronic
    8. Integra Lifesciences Corporation
    9. Baxter
    10. Abbott Laboratories
    11. Polyganics
    12. St. Jude Medical
    13. Cyberonics, Inc
    14. Soterix Medical, Inc.
    15. Nevro
    16. Kerimedical
    17. Biowave Corporation
    18. Neuronetics, Inc.
    19. Synapse Biomedical, Inc.
    20. Other Prominent Players
  14. Key Strategic Recommendations

 

*Financial information of non-listed Companies will be provided as per availability

**The segmentation and the companies are subjected to modifications based on in-depth study during the final deliverable.

 

List of Figures

 

 

Fig1: Global Nerve Repair and Regeneration Segmentation

 

Fig 2: Global Nerve Repair and Regeneration Value Chain Analysis,

 

Fig 3: Company Market Share Analysis, 2020

 

Fig 4: Global Nerve Repair and Regeneration Size, By Value (USD Billion), 2017-2027

 

Fig 5: Global Nerve Repair and Regeneration Share (%), By Product, By Value, 2017-2027

 

Fig 6: Global Nerve Repair and Regeneration Share (%), By Application, By Value, 2017-2027

 

Fig 7: Global Nerve Repair and Regeneration Share (%), By Country, By Value, 2017-2027

 

Fig 8: North America Nerve Repair and Regeneration Size, By Value (USD Billion), 2017-2027

 

Fig 9: North America Nerve Repair and Regeneration Share (%), By Product, By Value, 2017-2027

 

Fig 10: North America Nerve Repair and Regeneration Share (%), By Application, By Value, 2017-2027

 

Fig 11: North America Nerve Repair and Regeneration Share (%), By Country, By Value, 2017-2027

 

Fig 12: Europe Nerve Repair and Regeneration Size, By Value (USD Billion), 2017-2027

 

Fig 13: Europe Nerve Repair and Regeneration Share (%), By Product, By Value, 2017-2027

 

Fig 14: Europe Nerve Repair and Regeneration Share (%), By Application, By Value, 2017-2027

 

Fig 15: Europe Nerve Repair and Regeneration Share (%), By Country, By Value, 2017-2027

 

Fig 16: the Asia-Pacific Nerve Repair and Regeneration Size, By Value (USD Billion), 2017-2027

 

Fig 17: the Asia-Pacific Nerve Repair and Regeneration Share (%), By Product, By Value, 2017-2027

 

Fig 18: the Asia-Pacific Nerve Repair and Regeneration Share (%), By Application, By Value, 2017-2027

 

Fig 19: Asia-Pacific Nerve Repair and Regeneration Share (%), By Country, By Value, 2017-2027

 

Fig 20: Latin America Nerve Repair and Regeneration Size, By Value (USD Billion), 2017-2027

 

Fig 21: Latin America Nerve Repair and Regeneration Share (%), By Product, By Value, 2017-2027

 

Fig 22: Latin America Nerve Repair and Regeneration Share (%), By Application, By Value, 2017-2027

 

Fig 23: Latin America Nerve Repair and Regeneration Share (%), By Country, By Value, 2017-2027

 

Fig 24: Middle East & Africa Nerve Repair and Regeneration Size, By Value (USD Billion), 2017-2027

 

Fig 25: Middle East & Africa Nerve Repair and Regeneration Share (%), By Product, By Value, 2017-2027

 

Fig 26: Middle East & Africa Nerve Repair and Regeneration Share (%), By Application, By Value, 2017-2027

 

Fig 27: Middle East & Africa Nerve Repair and Regeneration Share (%), By Region, By Value, 2017-2027

 

 

 

List of Tables

 

 

Table 1: Global Nerve Repair and Regeneration Size, By Product, By Value, 2017-2027

 

Table 2: Global Nerve Repair and Regeneration Size, By Application, By Value (USD Billion), 2017-2027

 

Table 3: Global Nerve Repair and Regeneration Size, By Region, By Value (USD Billion), 2017-2027

 

Table 4: North America Nerve Repair and Regeneration Size, By Product, By Value (USD Billion), 2017-2027

 

Table 5: North America Nerve Repair and Regeneration Size, By Application, By Value (USD Billion), 2017-2027

 

Table 6: North America Nerve Repair and Regeneration Size, By Country, By Value (USD Billion), 2017-2027

 

Table 7: Europe Nerve Repair and Regeneration Size, By Product, By Value (USD Billion), 2017-2027

 

Table 8: Europe Nerve Repair and Regeneration Size, By Application, By Value (USD Billion), 2017-2027

 

Table 9: Europe Nerve Repair and Regeneration Size, By Country, By Value (USD Billion), 2017-2027

 

Table 10: the Asia-Pacific Nerve Repair and Regeneration Size, By Product, By Value (USD Billion), 2017-2027

 

Table 11: the Asia-Pacific Nerve Repair and Regeneration Size, By Application, By Value (USD Billion), 2017-2027

 

Table 12: the Asia-Pacific Nerve Repair and Regeneration Size, By Country, By Value (USD Billion), 2017-2027

 

Table 13: Latin America Nerve Repair and Regeneration Size, By Product, By Value (USD Billion), 2017-2027

 

Table 14: Latin America Nerve Repair and Regeneration Size, By Application, By Value (USD Billion), 2017-2027

 

Table 15: Latin America Nerve Repair and Regeneration Size, By Country, By Value (USD Billion), 2017-2027

 

Table 16: The Middle-East & Africa Nerve Repair and Regeneration Size, By Product, By Value (USD Billion), 2017-2027

 

Table 17: The Middle-East & Africa Nerve Repair and Regeneration Size, By Application, By Value (USD Billion), 2017-2027

 

Table 18: The Middle-East & Africa Nerve Repair and Regeneration Size, By Country, By Value (USD Billion), 2017-2027

 

Table 19: Stryker Financial Analysis

Table 20: Stryker Business Overview

Table 21: Neuropace Inc. Financial Analysis

Table 22: Neuropace Inc. Business Overview

Table 23: Livanova Analysis

Table 24: Livanova Overview

Table 25: Boston Scientific Corporation Analysis

Table 26: Boston Scientific Corporation Overview

Table 27: Axogen Corporation Financial Analysis

Table 28: Axogen Corporation Business Overview

Table 29: Neuronetics Financial Analysis

Table 30: Neuronetics Business Overview

Table 31: Medtronic Financial Analysis

Table 32: Medtronic Business Overview

Table 33: Integra Lifesciences Corporation Financial Analysis

Table 34: Integra Lifesciences Corporation Business Overview

Table 35: Baxter Financial Analysis

Table 36: Baxter Business Overview

Table 37: Abbott Laboratories Financial Analysis

Table 38: Abbott Laboratories Business Overview

Table 39: Polyganics Financial Analysis

Table 40: Polyganics Financial Analysis

Table 41: St. Jude MedicalFinancial Analysis

Table 42: St. Jude MedicalBusiness Overview

Table 43: Cyberonics, IncFinancial Analysis

Table 44: Cyberonics, IncBusiness Overview

Table 45: Soterix Medical, Inc.Financial Analysis

Table 46: Soterix Medical, Inc.Business Overview

Table 47: NevroFinancial Analysis

Table 48: NevroBusiness Overview

Table 49: KerimedicalFinancial Analysis

Table 50: KerimedicalBusiness Overview

Table 51: Biowave CorporationFinancial Analysis

Table 52: Biowave CorporationBusiness Overview

Table 53: Neuronetics, Inc.Financial Analysis

Table 54: Neuronetics, Inc.Business Overview

Table 55: Synapse Biomedical, Inc.Financial Analysis

Table 56: Synapse Biomedical, Inc.Business Overview